FEATURED POST
MediCarbone Receives NSF SBIR Phase I Funding
MediCarbone announced it received an NSF SBIR Phase I award for $273,563 for the design and development of its minimally-invasive orthopedic fracture fixation technology, which uses an intramedullary sleeve and injectable, light-triggered bone cement.
See us at the Orthopedic Research Society Annual Meeting (ORS)
MediCarbone will be in attendance at the Orthopedic Research Society Annual Meeting (ORS), February 2-6, 2024 at the Long Beach Convention Center
MediCarbone patent information
MediCarbone has 1 licensed patent from the University of Arizona; 2 patents approved for publishing and many other patents in the
MediCarbone receives NSF SBIR Phase I funding
MediCarbone announced it received an NSF SBIR Phase I award for $273,563 for the design and development of its minimally-invasive orthopedic fracture
UAVenture Capital Fund Invests in New Uses of Carbon Fiber
UAVenture Capital Fund II LLC, an investment fund managed by UAVenture Capital LLC, invested in MediCarbone Inc. Financial terms of the